Skip to Main
The-Landscape-for-Lipid-Nanoparticle-Based-Genomic-Medicines-Cover

The Landscape for Lipid-Nanoparticle-Based Genomic Medicines

Malvika Verma Imran Ozer Wen Xie Ryan Gallagher Alexandra Teixeira Michael Choy

LNPs are well-positioned to support the emerging field of genomic medicines, for which safety and efficient in vivo delivery has been a key challenge.